ARCHIVES

Translation Of “New Biology” Into Clinical Use Identified By DeVita As NCI’s Major Challenge

This article is from The Cancer Letter archive.

Vol. 11 No. 33 | August 16, 1985

Download PDF Visit The Full Archive

Related Articles

Waxman Hearing Turns Out Strong Support For Cancer Program Renewal

February 29, 1980

Rituximab Maintenance Improves Survival In Relapse

February 27, 2009

Senate Confirms McClellan For FDA

October 25, 2002

NCI, ACRIN Begin Trial Comparing Digital Mammography To Standard.

September 7, 2001

Toxic Substance Act Would Affect Cancer Program

March 21, 1975

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

February 4, 1983